During the last week, kininase 1 was blocked with Mergetpa (1 mg kg−1 twice daily, s.c.)and the impact was determined on insulin resistance (HOMA index), metabolic hormone levels, oxidative stress and the expression of several markers of inflammation by western blot and qRT-PCR. The gene discussed is CPN1; the disease is Insulin resistance.